The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $287.77

Today's change-1.77 -0.61%
Updated December 9 4:15 PM EST. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $287.77

Today's change-1.77 -0.61%
Updated December 9 4:15 PM EST. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$1.77

Biogen Inc closed lower Friday, dropping (U.S.)$1.77 or 0.61% to (U.S.)$287.77. Over the last five days, shares have lost 3.17% and are down 6.06% for the last year to date. This security has underperformed the S&P 500 by 9.24% during the last year.

Key company metrics

  • Open(U.S.) $305.24
  • Previous close(U.S.) $289.54
  • High(U.S.) $306.98
  • Low(U.S.) $281.79
  • Bid / Ask(U.S.) $285.25 / (U.S.) $291.19
  • YTD % change-6.06%
  • Volume6,257,637
  • Average volume (10-day)1,884,003
  • Average volume (1-month)1,871,173
  • Average volume (3-month)1,583,896
  • 52-week range(U.S.) $223.02 to (U.S.) $333.65
  • Beta0.73
  • Trailing P/E16.27×
  • P/E 1 year forward14.34×
  • Forward PEG1.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $17.69
Updated December 9 4:15 PM EST. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,9562,8942,7272,839
Total other revenue--------
Total revenue2,9562,8942,7272,839
Gross profit2,5392,5242,4142,508
Total cost of revenue417370313332
Total operating expense1,5311,4341,3481,671
Selling / general / administrative463492497583
Research & development529473437542
Depreciation / amortization100938997
Interest expense (income), net operating--------
Unusual expense (income)181112118
Other operating expenses, total5-6----
Operating income1,4251,4611,3781,168
Interest income (expense), net non-operating-66-66-63-67
Gain (loss) on sale of assets--------
Other--------
Income before tax1,3671,4021,3261,086
Income after tax1,0301,048969829
Income tax, total337354356257
Net income1,0331,050971832
Total adjustments to net income--------
Net income before extra. items1,0331,050971832
Minority interest3123
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0331,050971832
Inc. avail. to common incl. extra. items1,0331,050971832
Diluted net income1,0331,050971832
Dilution adjustment--------
Diluted weighted average shares219219219221
Diluted EPS excluding extraordinary itemsvalue per share4.714.784.433.77
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.774.824.474.17